The role of patient preferences in Market Access

Learn how HTAs, HCPs and patients’ associations value patient preferences

Register Download Material
  • 2. Jun 2021

1 day course

Danish

5.800,- DKK ex VAT
(app. 780,- EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Home > Courses > The role of patient preferences in Market Access

Summary

Approval bodies such as the FDA, EMA and NICE will soon focus on patient preference evidence when approving new medical treatments. It is therefore inevitable that pharma HQs will begin generating such evidence and expecting affiliates to utilize such evidence in Market Access and Commercial work.

At this course you gain an understanding of what Patient Preferences is, which methods to generate and measure patient preferences and how they can be used in a Danish context when working with Payers, HCPs and patient organizations.
 

Key words

  • Patient preferences
  • Patient Advocacy
  • Medical Affairs
  • Market Access
  • Stakeholder management
  • Health data
  • Evidence
  • Medicine evaluation
  • Danish Medicines Council

Course calendar

Start 2. Jun 2021
Registration deadline 2. Jun 2021
2. Jun 20219:00 - 16:00
Atrium
Lersø Parkallé 101
2100 København Ø

What you will learn

  1. What patient preferences are and how they can be generated quantitatively and qualitatively
  2. How international approval bodies work with patient preferences, including the expectations of the Danish Medicines Council for the role played by the preferences in the Council's work in the future
  3. The relationship between HQ and subsidiaries regarding patient preferences
  4. How healthcare professionals and patients’ associations work with patient preferences in everyday life, and how pharmaceutical companies can contribute to that work

What your company will get

  1. An employee who understands patient preferences and how these can be utilised in cross-functional work during the product lifecycle from development and pre-approval to launch and post-launch
  2. An employee with knowledge about how patient preferences are included in approval bodies’ decision-making processes
Available start dates
Download Material

Want to know more about this course?

Contact Client Manager Birger Flinthagen at +45 39 15 09 06

Send me an email

You may also be interested in these courses